title: Non-additive interaction between nicotinic cholinergic and P2X purine receptors in guinea-pig enteric neurons in culture.
abstract: 1. Acetylcholine (ACh)-activated currents and their interaction with ATP-activated currents were studied in primary cultures of myenteric neurons from guinea-pig small intestine using patch clamp techniques. Peak currents caused by co-application of ACh (1 mM) and ATP (300 microM) were 78 +/- 2 % of the sum of currents activated by each agonist alone (P < 0.05, n = 29). Reversal potentials measured during co-application of ACh and ATP did not differ from those measured during application of ACh or ATP alone. Addition of BAPTA (10 mM) to the pipette solution or replacement of extracellular Ca2+ with Na+ did not prevent occlusion. 2. Responses caused by co-application of 5-HT (300 microM), acting at 5-HT3 receptors, and ACh (3 mM) or ATP (1 mM) were additive (94 +/- 3 or 96 +/- 4 %, respectively, of the sum of currents activated by 5-HT and ACh or ATP alone; P > 0.05). Currents caused by GABA (1 mM), acting at GABAA receptors, and ACh (3 mM) or ATP (1 mM) were also additive (105 +/- 4 or 100 +/- 3 %, respectively, of the sum of currents activated by GABA and ACh or GABA and ATP applied separately; P > 0. 05). 3. Single channel currents caused by ACh and ATP in the same outside-out patches were less than additive (85 +/- 10 % of the predicted sum, P < 0.05). 4. P2X receptors and nicotinic cholinergic receptors (nAChRs) are linked in a mutually inhibitory manner in guinea-pig myenteric neurons. The functional interaction does not involve ligand binding sites, Ca2+-dependent mechanisms, a change in the driving force for Na+ or cytoplasmic signalling mechanisms.
authors.affiliation: Department of Pharmacology and Toxicology and the Neuroscience Program, Michigan State University, East Lansing, MI,, USA. zhoux@pilot.msu.edu
authors.forename: X
authors.initials: X
authors.lastname: Zhou
authors.forename: J J
authors.initials: JJ
authors.lastname: Galligan
mesh_terms: D000109:Acetylcholine / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000494:pharmacology; D000818:Animals; D002412:Cations / Q000378:metabolism; D002478:Cells, Cultured; D004558:Electric Stimulation; D004594:Electrophysiology; D006168:Guinea Pigs; D007413:Intestinal Mucosa / Q000187:drug effects / Q000294:innervation*; D015640:Ion Channel Gating / Q000187:drug effects / Q000502:physiology; D007473:Ion Channels / Q000187:drug effects / Q000378:metabolism*; D007700:Kinetics; D008564:Membrane Potentials / Q000187:drug effects / Q000502:physiology; D009474:Neurons / Q000187:drug effects / Q000378:metabolism*; D018722:Nicotinic Agonists / Q000494:pharmacology; D018733:Nicotinic Antagonists / Q000494:pharmacology; D018408:Patch-Clamp Techniques; D058910:Purinergic P2 Receptor Agonists; D058919:Purinergic P2 Receptor Antagonists; D011978:Receptors, Nicotinic / Q000187:drug effects / Q000378:metabolism*; D018048:Receptors, Purinergic P2 / Q000378:metabolism*; D011985:Receptors, Serotonin / Q000187:drug effects
chemical_list: D002412:Cations; D007473:Ion Channels; D018722:Nicotinic Agonists; D018733:Nicotinic Antagonists; D058910:Purinergic P2 Receptor Agonists; D058919:Purinergic P2 Receptor Antagonists; D011978:Receptors, Nicotinic; D018048:Receptors, Purinergic P2; D011985:Receptors, Serotonin; D000255:Adenosine Triphosphate; D000109:Acetylcholine